Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Actavis UK Ltd
Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 15/12/2011
PIL Paroxetine Tablets 20mg, 30mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to manufacturer contact details
Updated on 13/10/2011 and displayed until 15/12/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 21/04/2011 and displayed until 13/10/2011
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 19/10/2010 and displayed until 21/04/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/10/2010 and displayed until 19/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 08/12/2009 and displayed until 13/10/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/04/2008 and displayed until 08/12/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/12/2007 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 08/05/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to how to administer the medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to instructions about overdose
Updated on 10/11/2006 and displayed until 08/05/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/06/2006 and displayed until 10/11/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  paroxetine hydrochloride anhydrous